retatrutide for type 1 diabetes Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA The Effect of Retatrutide on

Were now seeing a real shift: from weekly injections to once-daily pills Two oral GLP-1 options are now leading this transition: #Wegovy pill (oral semaglutide) first to market #Foundayo (orforglipron) newest entrant But heres what you must know

When it comes to managing chronic conditions like type 2 diabetes and obesity, semaglutide has emerged as a game-changer

Its dual mechanism makes it a powerful tool for treating obesity, insulin resistance, and type 2 diabetes

When it comes to managing weight, many individuals turn to medications like Saxenda for assistance

GLP-1 medications like Zepbound can trigger or worsen acid reflux in some patients

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity